Cora Capital Advisors LLC Astrazeneca PLC Transaction History
Cora Capital Advisors LLC
- $235 Billion
- Q3 2025
A detailed history of Cora Capital Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Cora Capital Advisors LLC holds 3,976 shares of AZN stock, worth $355,454. This represents 0.13% of its overall portfolio holdings.
Number of Shares
3,976
Previous 3,964
0.3%
Holding current value
$355,454
Previous $277 Million
10.12%
% of portfolio
0.13%
Previous 0.12%
Shares
10 transactions
Others Institutions Holding AZN
# of Institutions
1,498Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...